Tourniquet-Test in HHT

U

University Hospital Essen

Status

Active, not recruiting

Conditions

HHT

Treatments

Diagnostic Test: Tourniquet Test

Study type

Interventional

Funder types

Other

Identifiers

NCT06266624
Tourniquet in HHT

Details and patient eligibility

About

The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.

Full description

The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.

Enrollment

92 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • In patients with confirmed HHT diagnosis (≥ 3 Curaçao criteria or positive molecular genetics)
  • aged over 18 years

Exclusion criteria

if inclusion criteria does not apply

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

92 participants in 1 patient group

Tourniquet Test
Experimental group
Description:
Patients with HHT patients who undergo the Tourniquet Test
Treatment:
Diagnostic Test: Tourniquet Test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems